Luigi Costa, Noema Pharma CEO
Noema Pharma raises $112M Series B to advance CNS disorder pipeline with Roche candidates
Swiss biotech Noema Pharma jumpstarted back in 2020 with a $60 million Series A financing round. Today, it’s wrapping up its Series B round with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.